SCHEMBL20535409

SCHEMBL20535409

Cc1ccc2ccccc2c1S(=O)(=O)NCc1ccc(Br)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 1/20 0.45
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
CYP19A1 P11511 2/20 0.43
LMNA P02545 2/20 0.43
THRB P10828 1/20 0.42
CNR1 P21554 4/20 0.41
NR3C1 P04150 1/20 0.41
NR3C2 P08235 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR2F2 P24468 1/20 0.40
HTT P42858 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960053 0.75 LMNA (0.68) MAPTSMN1; SMN2KMT2AMEN1CYP19A1
SCHEMBL3844980 0.74 CYP2A6 (0.56) CA9KMT2ACYP1A2CYP3A4ATM
SCHEMBL21838561 0.72 CNR1 (0.41) MAPTCNR1NR3C1NR3C2
SCHEMBL20669815 0.72 ALDH1A1 (0.48) TP53KMT2AMEN1LMNAL3MBTL1
SCHEMBL5960098 0.70 KEAP1 (0.76) CA12CA9MAPTSMN1; SMN2CYP19A1
SCHEMBL5166003 0.69 SMN1; SMN2 (0.60) CA12CA9MAPTSMN1; SMN2TP53
SCHEMBL20535091 0.68 CYP1A2 (0.36) MAPTSMN1; SMN2KMT2AMEN1CYP1A2
SCHEMBL5610250 0.68 CYP2A6 (0.52) CA9KMT2ACYP1A2CYP3A4ATM
SCHEMBL498824 0.68 CYP2A6 (0.52) CA9MAPTTP53KMT2ACYP1A2
SCHEMBL31603822 0.68 CYP2A6 (0.52) CA9KMT2AMEN1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2020-04-16 US disclosed
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2020-04-16 US disclosed
EP-3609880-A1 LIVER X RECEPTORS (LXR) MODULATORS Phenex-FXR GmbH (DE) 2020-02-19 EP disclosed
CN-110546144-A Liver X Receptor (LXR) modulators PHENEX FXR GMBH 2019-12-06 CN disclosed
WO-2018188795-A1 LIVER X RECEPTORS (LXR) MODULATORS PHENEX-FXR GMBH (DE) 2018-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115357-A1 LIVER X RECEPTORS (LXR) MODULATORS NR1H2, NR1H3, NR1H4 CA12 4480/4885CA9 4586/4885MAPT 4430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.